Grantham, Mayo, Van Otterloo & Co (GMO)’s Avanos Medical AVNS Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q3 | – | Sell |
-19,590
| Closed | -$501K | – | 584 |
|
2023
Q2 | $501K | Buy |
19,590
+1,690
| +9% | +$43.2K | ﹤0.01% | 558 |
|
2023
Q1 | $532K | Buy |
17,900
+10,200
| +132% | +$303K | ﹤0.01% | 554 |
|
2022
Q4 | $208K | Buy |
+7,700
| New | +$208K | ﹤0.01% | 676 |
|
2018
Q2 | – | Sell |
-13,900
| Closed | -$641K | – | 541 |
|
2018
Q1 | $641K | Hold |
13,900
| – | – | ﹤0.01% | 426 |
|
2017
Q4 | $642K | Buy |
13,900
+7,400
| +114% | +$342K | ﹤0.01% | 417 |
|
2017
Q3 | $293K | Buy |
6,500
+500
| +8% | +$22.5K | ﹤0.01% | 460 |
|
2017
Q2 | $236K | Buy |
6,000
+300
| +5% | +$11.8K | ﹤0.01% | 496 |
|
2017
Q1 | $217K | Buy |
+5,700
| New | +$217K | ﹤0.01% | 508 |
|